HealthcareServices

Global Outpatient Oncology Infusion Market Report 2026–2035: Key Forecasts and Growth Areas

February 27, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the outpatient oncology infusion market from 2026–2035 with trusted insights from The Business Research Company

How is the Outpatient Oncology Infusion Market size predicted to change over the forecast window of 2026–2035?

The outpatient oncology infusion market size has demonstrated robust growth in recent years. It is anticipated to expand from $14.02 billion in 2025 to $15.12 billion in 2026, at a compound annual growth rate (CAGR) of 7.8%. This historical growth can be attributed to several factors including increasing cancer prevalence rates, the expansion of outpatient oncology infrastructure, the adoption of infusion-based therapies, improved survival rates necessitating ongoing treatment, and the availability of advanced infusion devices.

The outpatient oncology infusion market is projected to experience substantial expansion over the upcoming years. Its size is anticipated to reach $20.21 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. This forecasted growth stems from several factors, including the escalating demand for precision oncology treatments, increased investments in outpatient infusion centers, wider availability of home-compatible infusion technologies, a heightened emphasis on cost-effective cancer care, and greater integration of digital oncology monitoring. Key developments expected during this period involve a growing preference for outpatient cancer treatment approaches, the increased uptake of targeted and immunotherapies, expanded utilization of smart infusion pumps, the proliferation of ambulatory infusion centers, and a reinforced commitment to patient-centric oncology care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25861&type=smp

Which Drivers Are Contributing To The Expansion Of The Outpatient Oncology Infusion Market?

The rising incidence of cancer diagnoses is anticipated to drive the future expansion of the outpatient oncology infusion market. Cancer refers to a collection of intricate diseases characterized by the unrestrained proliferation of abnormal cells, which can penetrate surrounding tissues and spread throughout the body. The increasing frequency of cancer cases is primarily a result of aging populations globally, as the likelihood of developing cancer significantly increases with age. Outpatient oncology infusion involves administering cancer treatments such as chemotherapy, immunotherapy, or targeted therapy in a clinical setting without requiring hospital admission, thus enabling patients to receive necessary care while maintaining their regular routines. For instance, in April 2024, Macmillan Cancer Support, a UK-based charity dedicated to providing practical, emotional, and financial assistance to those impacted by cancer, projected that the population living with cancer in the UK currently exceeds 3 million. This number is expected to climb to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer cases is acting as a key driver for the growth of the outpatient oncology infusion market.

What Segment Categories Are Covered In The Outpatient Oncology Infusion Market?

The outpatient oncology infusion market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors

2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy

3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers

4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps

2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets

3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas

4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors

Which Trends Are Shaping Activity Within The Outpatient Oncology Infusion Market?

Leading companies in the outpatient oncology infusion market are prioritizing technological advancements in infusion systems, particularly next-generation smart infusion pumps, to enhance medication safety and optimize chemotherapy delivery. These next-generation smart infusion pumps are digitally connected devices equipped with sophisticated dose-error reduction software, integrated drug libraries, and real-time connectivity to minimize errors and standardize oncology treatments. For instance, in April 2024, Baxter International Inc., a US-based medical technology company, obtained U.S. Food and Drug Administration (FDA) 510(k) clearance for its Novum IQ large-volume infusion pump, making it available for U.S. ordering. This integrated hardware-software system provides precise large-volume infusions, incorporating embedded safety checks, dose-library enforcement, and connectivity for remote management. Baxter underscores its advanced safety architecture, improved usability, and compatibility with its wider infusion ecosystem. The pump is suitable for outpatient oncology infusion centers, ambulatory clinics, and hospitals, offering benefits such as heightened dosing accuracy, streamlined nursing workflows, and fewer delays or adverse events during chemotherapy administration.

Which Key Players Are Driving Competition In The Outpatient Oncology Infusion Market?

Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/outpatient-oncology-infusion-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Outpatient Oncology Infusion Market?

North America was the largest region in the outpatient oncology infusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Outpatient Oncology Infusion Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25861&type=smp

Browse Through More Reports Similar to the Global Outpatient Oncology Infusion Market 2026, By The Business Research Company

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Chemotherapy Infusion Pumps Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-infusion-pumps-global-market-report

Drug Infusion Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795